Elizabeth Ingram
Directeur Général chez Cipla Therapeutics, Inc.
Profil
Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.
Postes actifs de Elizabeth Ingram
Sociétés | Poste | Début |
---|---|---|
Cipla Therapeutics, Inc. | Directeur Général | - |
Anciens postes connus de Elizabeth Ingram
Sociétés | Poste | Fin |
---|---|---|
AVENUE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/10/2022 |
MANNKIND CORPORATION | Sales & Marketing | 01/06/2019 |
DEXCOM, INC. | Corporate Officer/Principal | 01/12/2017 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2014 |
Formation de Elizabeth Ingram
East Carolina University | Undergraduate Degree |
University of South Carolina | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
MANNKIND CORPORATION | Health Technology |
DEXCOM, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AVENUE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Cipla Therapeutics, Inc. |